Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

dc.contributor.authorRegan, Meredith M.
dc.contributor.authorPrice, Karen N.
dc.contributor.authorGiobbie-Hurder, Anita
dc.contributor.authorThürlimann, Beat
dc.contributor.authorGelber, Richard D.
dc.contributor.authorHorváth, Zsolt
dc.date.accessioned2016-12-29T07:11:36Z
dc.date.available2016-12-29T07:11:36Z
dc.date.issued2011
dc.date.pasync2017-12-01T09:43:39Z
dc.date.updated2017-12-01T09:43:39Z
dc.identifier.citationBreast Cancer Research. - 13 (2011), p. 209-224. -Breast Cancer Res. - 1465-5411
dc.identifier.issn1465-5411
dc.identifier.opachttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM066526
dc.identifier.urihttp://hdl.handle.net/2437/233427
dc.identifier.urlhttp://download.springer.com/static/pdf/953/art%253A10.1186%252Fbcr2837.pdf?originUrl=http%3A%2F%2Fbreast-cancer-research.biomedcentral.com%2Farticle%2F10.1186%2Fbcr2837&token2=exp=1482995569~acl=%2Fstatic%2Fpdf%2F953%2Fart%25253A10.1186%25252Fbcr2837.pdf*~hmac=d7eecaaf5b902a67c567ff07815d48f77d4fbe4920047a45ec5f7198514037a2
dc.languageeng
dc.rights.accessopen access journal
dc.rights.ownerBioMed Central
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleInterpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
dc.typefolyóiratcikk
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_0_80. közlemény.pdf
Méret:
729.18 KB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat